miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses.

Pathology, research and practice 2023 Jul

filter terms:

Retinoblastoma (RB) is a rare tumor in children, but it is the most common primitive intraocular malignancy in childhood age, especially those below three years old. The RB gene (RB1) undergoes mutations in individuals with RB. Although mortality rates remain high in developing countries, the survival rate for this type of cancer is greater than 95-98% in industrialized countries. However, it is lethal if left untreated, so early diagnosis is essential. As a non-coding RNA, miRNA significantly impacts RB development and treatment resistance because it can control various cellular functions. In this review, we illustrate the recent advances in the role of miRNAs in RB. That includes the clinical importance of miRNAs in RB diagnosis, prognosis, and treatment. Moreover, the regulatory mechanisms of miRNAs in RB and therapeutic interventions are discussed. Copyright © 2023 Elsevier GmbH. All rights reserved.

Citation

Ahmed S Doghish, Hebatallah Ahmed Mohamed Moustafa, Mohammed S Elballal, Omnia M Sarhan, Samar F Darwish, Wagiha S Elkalla, Osama A Mohammed, Asmaa M Atta, Nourhan M Abdelmaksoud, Hesham A El-Mahdy, Ahmed Ismail, Sherif S Abdel Mageed, Mahmoud A Elrebehy, Amr M Abdelfatah, Ahmed I Abulsoud. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses. Pathology, research and practice. 2023 Jul;247:154537